Literature DB >> 22610055

Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome.

Yee-Hsuan Chiou1, Lin-Yu Wang, Tzu-Hui Wang, Shiao-ping Huang.   

Abstract

BACKGROUND: Idiopathic nephrotic syndrome (INS) is the most frequent type of nephrotic syndrome that occurs in children. Its response to treatment with steroids varies. The aim of this study was to analyze the correlation between steroid metabolism-related genes and the response to steroid treatment.
METHODS: The patient cohort comprised 74 children with INS, of whom were 58 steroid-sensitive (SS) cases and 16 steroid-resistant (SR) cases. The genetic polymorphisms analyzed were those of the CYP3A5 gene (A6986G) and ABCB1 gene (C1236T, G2677T/A, and C3435T), and the polymorphisms between SS and SR children were compared.
RESULTS: C1236T in ABCB1 was associated with steroid resistance in INS children [odds ratio (OR) 2.65, 95 % confidence interval (CI) 1.01-6.94; p = 0.042] The frequency of the T allele was significantly higher in SR subjects than in SS subjects (0.81 vs. 0.62, respectively). A6986G in CYP3A5 showed a trend of association, but this association did not reach statistical significance (OR 2.63, 95 % CI 0.94-7.37; p = 0.059). No significant correlation was found between treatment response and G2677T/A or C3435T in ABCB1.
CONCLUSIONS: Our results indicate that among our pediatric patients with INS the C1236T polymorphism in the ABCB1 gene was associated with steroid resistance, while the A6986G polymorphism in the CYP3A5 gene showed a trend of association, but did not reach statistical significance, requiring further analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610055     DOI: 10.1007/s00467-012-2182-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

Review 1.  Genetic contribution to variable human CYP3A-mediated metabolism.

Authors:  Jatinder K Lamba; Yvonne S Lin; Erin G Schuetz; Kenneth E Thummel
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

2.  Expression of cytochrome P450 3A in amphibian, rat, and human kidney.

Authors:  E G Schuetz; J D Schuetz; W M Grogan; A Naray-Fejes-Toth; G Fejes-Toth; J Raucy; P Guzelian; K Gionela; C O Watlington
Journal:  Arch Biochem Biophys       Date:  1992-04       Impact factor: 4.013

3.  Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.

Authors:  Ping Xu; Zhi-Ping Jiang; Bi-Kui Zhang; Ji-Ying Tu; Huan-De Li
Journal:  Pharmacology       Date:  2008-09-23       Impact factor: 2.547

4.  MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

Authors:  Thomas Illmer; Ulrich S Schuler; Christian Thiede; Ute I Schwarz; Richard B Kim; Sebastian Gotthard; Daniel Freund; Ulrike Schäkel; Gerhard Ehninger; Markus Schaich
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 5.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02

6.  Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

Authors:  Eric Thervet; Dany Anglicheau; Barry King; Marie-Hélène Schlageter; Bruno Cassinat; Philippe Beaune; Christophe Legendre; Ann K Daly
Journal:  Transplantation       Date:  2003-10-27       Impact factor: 4.939

Review 7.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

Authors:  Michel Eichelbaum; Martin F Fromm; Matthias Schwab
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

8.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

9.  Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.

Authors:  P H Beaune; P G Kremers; L S Kaminsky; J De Graeve; A Albert; F P Guengerich
Journal:  Drug Metab Dispos       Date:  1986 Jul-Aug       Impact factor: 3.922

10.  Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

Authors:  Yvonne S Lin; Amy L S Dowling; Sean D Quigley; Federico M Farin; Jiong Zhang; Jatinder Lamba; Erin G Schuetz; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

View more
  5 in total

Review 1.  A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease.

Authors:  Maria Tziastoudi; Georgios Pissas; Georgios Raptis; Christos Cholevas; Theodoros Eleftheriadis; Evangelia Dounousi; Ioannis Stefanidis; Theoharis C Theoharides
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 2.  A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: Susceptibility and steroid responsiveness.

Authors:  Shi-Sheng Han; Yan-Qiu Xu; Yan Lu; Xiang-Chen Gu; Yi Wang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

3.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

Review 4.  Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.

Authors:  Anne M Schijvens; Rob Ter Heine; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

5.  Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach.

Authors:  Most Nazma Parvin; Md Abdul Aziz; Sikder Nahidul Islam Rabbi; Mir Md Abdullah Al-Mamun; Mohammed Hanif; Md Saiful Islam; Mohammad Safiqul Islam
Journal:  J Adv Res       Date:  2021-02-17       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.